These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34826158)

  • 1. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from the OPEN survey.
    O'Donnell S; Cooper D; Chen Y; Ballhausen H; Lewis DM; Froment T; Anna Gajewska K; Tappe A; Skinner T; Cleal B; Braune K
    Diabetes Res Clin Pract; 2023 Mar; 197():110235. PubMed ID: 36581143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.
    Braune K; Lal RA; Petruželková L; Scheiner G; Winterdijk P; Schmidt S; Raimond L; Hood KK; Riddell MC; Skinner TC; Raile K; Hussain S;
    Lancet Diabetes Endocrinol; 2022 Jan; 10(1):58-74. PubMed ID: 34785000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Adults with Type 1 Diabetes Are Navigating the Challenges of Open-Source Artificial Pancreas Systems: A Qualitative Study.
    Schipp J; Skinner T; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabetes Technol Ther; 2021 Aug; 23(8):546-554. PubMed ID: 33720767
    [No Abstract]   [Full Text] [Related]  

  • 12. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Schipp J; Skinner TC; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabet Med; 2022 May; 39(5):e14708. PubMed ID: 34599617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.
    Murray JA; Clayton MF; Litchman ML
    J Diabetes Sci Technol; 2020 Nov; 14(6):1017-1021. PubMed ID: 31876176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes.
    Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M
    J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID.
    Lewis D
    J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.
    Shahid A; Lewis DM
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.